sprite-preloader
Freitag, 24.02.2017 Börsentäglich über 12.000 News von 554 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoBMJ warns of global impact of Trump on R&D, regulation
DoFDA clears 7SBio's 'virtually painless' blood collection device
DoFDA clears Immunexpress' RNA-based, whole-blood sepsis Dx
DoImmusanT's celiac disease immunotherapy passes first clinical test
DoArgos kidney cancer vax fails phase 3 futility review, future in doubt
DoCancer startup PMV Pharma gains impressive $74M B round
MiAfter Merck KGaA rejection, Apitope advances MS drug
MiClouded by MD Anderson audit, IBM Watson unveils new partnerships
MiVBL posts additional data from phase 2 thyroid cancer trial
MiSarepta sells Exondys 51 PRV to Gilead for $125M
MiCidara fails phase 2 study, drops med in vulvovaginal candidiasis
MiFDA accepts Pfizer's blood cancer candidate for speedy review
DiCancer player Nordic Nanovector stokes takeover talk
Di'Spiderweb' of lung cancer proteins snares new drug targets
DiGene therapy succeeds in dogs with muscle disease
DiWith FDA nod, Biotronik debuts first coronary stent in U.S.
DiWhy Are Life Science Companies Locating in Greater Fort Lauderdale?
DiNew culture method boosts T cells' ability to recognize multiple cancers
DiTrial shows ArmaGen drug improves cognition in Hurler patients
17.02.Daiichi, ArQule's tivantinib fails in phase 3 liver cancer test
17.02.British investment firm Arix Bioscience hits £100M IPO target
17.02.Takeda, TiGenix stem cell therapy shows sustained effect
17.02.Sage Therapeutics fuels, then dampens, its own M&A rumors
17.02.Gilead sells phase 2 addiction drug to ex-CVT team
17.02.Chutes & Ladders: J&J vet Bridget Ross jumps to Henry Schein